Filing Details
- Accession Number:
- 0001209191-22-040094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-01 15:06:33
- Reporting Period:
- 2022-06-01
- Accepted Time:
- 2022-07-01 15:06:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-01 | 76 | $2.05 | 47,219 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-02 | 76 | $2.08 | 47,295 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-03 | 76 | $2.09 | 47,371 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-06 | 81 | $2.07 | 47,452 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-07 | 60 | $2.08 | 47,512 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-08 | 81 | $2.12 | 47,593 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-09 | 81 | $2.09 | 47,674 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-10 | 81 | $2.04 | 47,755 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-13 | 81 | $2.01 | 47,836 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-14 | 81 | $2.02 | 47,917 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-15 | 81 | $1.98 | 47,998 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-16 | 81 | $1.95 | 48,079 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-17 | 81 | $1.94 | 48,160 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-21 | 86 | $1.97 | 48,246 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-22 | 82 | $1.99 | 48,328 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-23 | 86 | $2.01 | 48,414 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-24 | 86 | $2.11 | 48,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-27 | 15 | $2.06 | 48,515 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-28 | 79 | $2.06 | 48,594 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-29 | 86 | $2.11 | 48,680 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-30 | 86 | $2.08 | 48,766 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
Billionaire Hedge Funds
